Best Practices

Led by a husband-and-wife duo–one a pharmacy professor and the other a chemistry professor–the research team has now set its sights on finding existing drugs to treat COVID-19 and other SARS coronaviruses.

“These patients need appropriate followup. If one thing doesn’t work try something else. Most of these patients will respond," said clinical professor Dr. Stephen Field. But what should be done with the remaining 30% of patients who are refractory or unresponsive?

The legacy of residential schools is not just in the intergenerational trauma and impacts on Indigenous families and communities—it is also in the healthcare system.

As Canada's medical community continues to look for ways to eliminate discrimination in healthcare, the College of Physicians and Surgeons of Nova Scotia is moving to “regulate racism out of medicine.”

U.S. study compares 81 mg vs 325 mg ASA to lower cardiovascular risk and mortality in patients with established atherosclerotic cardiovascular disease.

Tezepelumab is associated with reduced exacerbations, hospitalizations and ER visits in people with severe, uncontrolled asthma. It may also challenge the current step of biomarker assessment before initiating treatment with a biologic.

OMA sections to give more feedback on report in 2022